Explore UAB

Are you 18 years or older? Are you being treated with lifestyle changes or treated with one or more oral diabetes medications?

At a glance:

The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 78 week research study to look into how well semaglutide once weekly medicine works in participants with obesity and type 2 diabetes.

About the Study

Qualified participants will receive study drug free of charge and may be compensated for time and travel.

PI: Dr. Tim Garvey

Contact

Tracie Thomas
205-996-4015
This email address is being protected from spambots. You need JavaScript enabled to view it.